NCT04565379 - Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

April 13, 2021

Study Completion Date

April 13, 2021

Conditions

COVID19 Pneumonia

Interventions

DRUG

NuSepin® 0.1 mg

DRUG

NuSepin® 0.2 mg

DRUG

Placebo

Normal Saline

Trial Locations (5)

Ramnicu Sarat Clinical Hospital, Râmnicu Sărat

"Leon Daniello Clinical Hospital of Pneumophtisiology Cluj-Napoca Pneumology Clinic", Cluj-Napoca

"Clinical Hospital for Infectious Diseases and Pneumophtisiology Victor Babes, Craiova Infectious Diseases Clinic for Adults", Craiova

"Sf. Parascheva Infectious Diseases Clinical Hospital Iasi Infectious Diseases Department", Iași

"Sf. Ioan cel Nou Suceava County Emergency Hospital Infectious Diseases Department", Suceava